Birchtech is a special situation where a profitable, licensing-driven emissions business and a PFAS “star” are paired with a potentially balance-sheet-transforming $78M litigation windfall.
Overview
Birchtech Corp. enters 2026 at a pivotal inflection point, balancing a maturing legacy mercury emissions control franchise with the early commercialization of a PFAS-focused water purification platform. The investment case is driven by three major catalysts. First, Birchtech won a landmark U.S. District Court judgment (Delaware) against the CERT defendants for willful infringement of its SEA® patents, with a final award of approximately **$78.4M including pre-judgment interest**—a potentially non-dilutive cash inflow roughly comparable to the company’s market cap, though likely subject to appeal and collection timing risk. Second, the ME2C Air business is shifting structurally toward high-margin licensing: Q3’25 revenue rose 41% YoY to **$7.4M**, gross margin expanded to **54.8%**, and the company achieved GAAP profitability (**$0.8M net income**), reflecting successful conversion of litigation targets into recurring licensees. Third, WE2C Water moved from concept to commercialization as EPA PFAS regulations create a large compliance market; initial purchase orders (~$0.9M) and a partnership with Civil & Environmental Consultants (CEC) indicate a nascent revenue ramp. Key risks include coal’s long-term decline (despite near-term reliability tailwinds), litigation appeals/collectability uncertainty, and intense competition in water treatment from incumbents like Calgon and Xylem. At ~$4.15–$4.30/share (post reverse split), the report argues the market is primarily valuing current operations and underpricing both the litigation “option” and the PFAS upside.